Sign Up to like & get
recommendations!
0
Published in 2019 at "Journal of pharmacological and toxicological methods"
DOI: 10.1016/j.vascn.2019.106580
Abstract: INTRODUCTION DSM421, a dihydroorotate dehydrogenase inhibitor, was in preclinical development as a potential treatment option for malaria. When tested in a core battery of safety pharmacology assays, DSM421 did not produce any effects at oral…
read more here.
Keywords:
head;
head plethysmography;
plethysmography testing;
mortality ... See more keywords